Outcomes in Ankle Replacement Study (OARS).

Toby O Smith Jack R Dainty David T Loveday Andoni Toms Andrew J Goldberg Laura Watts Mark W Pennington Jill Dawson Jan H P van der Meulen Alexander J MacGregornull null

Published in: The bone & joint journal (2023)

TAA significantly benefits patients with end-stage ankle disease. The lack of substantial further overall change between six and 12 months suggests that capturing PROMs at six months is sufficient to assess the success of the procedure. Older patients and those with advanced radiological disease had the greater gains. These outcome predictors can be used to counsel younger patients and those with earlier ankle disease on the expectations of TAA.

Keyphrases

patient reported outcomes
end stage renal disease
chronic kidney disease
newly diagnosed
ejection fraction
prognostic factors
skeletal muscle